Navigation Links
3SBio Inc. to Present at the UBS Greater China Conference 2012
Date:1/9/2012

SHENYANG, China, Jan. 9, 2012 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced Mr. Bo Tan, 3SBio's chief financial officer will attend the UBS Greater China Conference 2012 in Shanghai on January 11, 2012. A copy of Mr. Tan's presentation will be archived at www.3sbio.com under the investor relations section.  

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China.  Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.  With headquarters and MP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see www.3SBio.com for more information.

Investor Contacts


Bo Tan
Chief Financial Officer
3SBio Inc.
Tel: + 86 24 2581-1820
ir@3SBio.com

Tom Folinsbee
Director of Investor Relations
3SBio Inc.
Tel: + 852 8191-6991
ir@3SBio.com


'/>"/>
SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. 3SBio Inc. Announces Results of 2011 Annual General Meeting
2. 3SBio Inc. Announces Unaudited First Quarter 2011 Results
3. 3SBio Inc. Schedules Unaudited First Quarter 2011 Results
4. 3SBio Inc. Schedules Unaudited Fourth Quarter and Fiscal Year 2010 Results
5. 3SBio Inc. Receives SFDA Approval for TPIAO Label Extension for the Treatment of ITP
6. 3SBio Inc. Announces Unaudited Third Quarter Results
7. 3SBio Inc. Announces Unaudited Second Quarter Results
8. 3SBio Inc. Schedules Second Quarter 2010 Unaudited Financial Results
9. 3SBio Inc. Announces Filing of Form 20-F With SEC
10. 3SBio Inc. To Report 2010 First Quarter Unaudited Financial Results on May 16, 2010
11. 3SBio Announces Changes to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... ... make clinical trial sites and study participants truly unified. TrialKit, a native mobile ... 21 CFR Part 11) research studies entirely on mobile devices. With TrialKit, clinical ...
(Date:7/18/2017)... ... July 18, 2017 , ... Sourcing custom glass or quartz ... and has the capabilities to properly execute your job can take many hours of ... is a sourcing portal designed to showcase the company’s capabilities and core custom categories, ...
(Date:7/18/2017)... ... July 18, 2017 , ... G-CON today ... and Trademark Office for its Patent Applications 14/858,857 and 13/669,785 both entitled Modular, ... patent applications further expand the protection of G-CON’s R&D investments and validate the ...
(Date:7/18/2017)... DC (PRWEB) , ... July 18, 2017 , ... ... the Allotrope Framework, and has released the first phase of the Allotrope Framework ... World’s Best Practices Awards were created to “not only elevate the critical role ...
Breaking Biology Technology:
(Date:6/14/2017)...  IBM (NYSE: IBM ) is introducing several innovative ... to developing collaboration between startups and global businesses, taking place ... the event, nine startups will showcase the solutions they have ... France is one ... a 30 percent increase in the number of startups created ...
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):